Kestra Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Kestra Investment Management's REGN Position: Q2 2026 in Review
Kestra Investment Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 659 shares worth $411K. The stake represents 0.01% of the portfolio and ranks #351 among its holdings. This is a return to the name: Kestra Investment Management previously reported a position in REGN as recently as Q1 2025.
Kestra Investment Management first reported a position in REGN in Q2 2024 and has held it in 5 quarters since. The position peaked at $898K in Q4 2024. 1,341 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Kestra Investment Management held 659 shares of Regeneron Pharmaceuticals worth $411K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Kestra Investment Management position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Kestra Investment Management's portfolio in Q2 2026, its #351 holding.
- Kestra Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
- Kestra Investment Management's Regeneron Pharmaceuticals position peaked at $898K in Q4 2024.
- 1,341 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.